Tarsus Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Jennison Associates LLC(5.7%)
Tarsus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(9.9%)
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lin Elizabeth Yeu
Tarsus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Frazier Life Sciences IX, L.P.(4.2%),FHMLS IX, L.P.(4.2%), etc.
Tarsus Pharmaceuticals | 8-K: Current report
Tarsus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.51%)
Tarsus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(9.9%)
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Morrison Scott W
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Morrison Scott W
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director LINK WILLIAM J PHD
Tarsus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Tarsus Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Tarsus Pharmaceuticals | 8-K: Tarsus Reports Second Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Crane Rosemary A
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Goldberg Andrew D.
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director LINK WILLIAM J PHD
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lin Elizabeth Yeu
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Morrison Scott W
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director CHAUDHURI BHASKAR
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director YARNO WENDY L
No Data
No Data